intoDNA is a company headquartered in Poland. Brouky records 1 investor associated with the company.
intoDNA develops the STRIDE® platform, which provides high-sensitivity, AI-driven assays for detecting and analyzing DNA damage and repair at the single-cell level to support pharmaceutical research and precision medicine.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.